HIV Drugs Market Analysis, Size, Strategic Assessment, Market Growth And Forecasts To 2030

HIV Drugs Market - By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase Strand Transfer Inhibitors (INSTIs), Others ) By Application (Hospital Pharmacies, Retail Pharmacies, Others) By Administration (Oral, Parenteral) And By Region, Opportunities And Strategies – Global Forecast To 2030

The global HIV drugs market reached a value of nearly $30,520.0 million in 2020, having increased at a compound annual growth rate (CAGR) of 8.1% since 2015. The market is expected to grow from $30,520.0 million in 2020 to $36,460.0 million in 2025 at a rate of 3.6%. The HIV drug market growth is mainly due to the growing prevalence of HIV and government initiatives which is expected to drive the demand for HIV drugs. The HIV drugs market is expected to grow from $36,460.0 million in 2025 to $40,303.1 million in 2030 at a CAGR of 2.0%.

The key drivers of the HIV drug market include:
Government initiatives and efforts towards implementing reforms have had a significant impact on the market, in both developed and developing countries. For instance, the Health Resources and Services Administration’s (HRSA) Bureau of Primary Health Care announced the availability of around $83 million for up to 300 health centers for the fiscal year 2021 Ending the HIV Epidemic- Primary Care HIV Prevention (PCHP) program. The PCHP funding is likely to expand HIV prevention services with the motive of decreasing the risk of HIV transmission across 57 geographic locations recognized by Ending the HIV Epidemic: A Plan for America. Additionally, in December 2020, the fiscal year budget passed included $386 million for the implementation of the EHE initiative along with $175 million for the Centers for Disease Control and Prevention (CDC) to reduce new HIV infections. Therefore, these government initiatives push the development of HIV drug demand and thereby contributing to the growth of the market in the forecast period.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/hiv-drugs-market

HIV drug Market Segmentation: -
By Type-
a) Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
b) Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
c) Protease Inhibitors
d) Integrase strand transfer inhibitors (INSTIs)
e) Others

By Application -
a) Hospital Pharmacies
b) Retail Pharmacies
c) Others

By Administration -
a) Oral
b) Parenteral

Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=4060&type=smp

By Geography - The HIV drug market is segmented Into
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4060

Some of the major key players involved in the HIV drug market are
1. Gilead Sciences, Inc
2. GlaxoSmithKline plc.
3. Johnson & Johnson
4. Merck & Co., Inc.
5. Boehringer Ingelheim International GmbH

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.